Research field (1)：
General surgery, pediatric surgery
Research theme for competitive and other funds (1)：
2015 - 2018 Elucidation of the significance of local and systemic immune responses in the therapeutic effect of preoperative chemotherapy for breast cancer
Papers (18)：
Fukui Reiko, Watanabe Takahiro, Morimoto Koji, Fujimoto Yukie, Nagahashi Masayuki, Ishikawa Eri, Hirota Seiichi, Miyoshi Yasuo. エストロゲン受容体陽性/HER2陰性乳癌において治療後にみられる腫瘍浸潤リンパ球の増加は術前補助内分泌療法への反応不良と有意に関連している(An increase in tumor-infiltrating lymphocytes after treatment is significantly associated with a poor response to neoadjuvant endocrine therapy for estrogen receptor-positive/HER2-negative breast cancers). Breast Cancer. 2023. 30. 5. 703-713
Fujimoto Yukie, Inoue Natsuko, Morimoto Koji, Watanabe Takahiro, Hirota Seiichi, Imamura Michiko, Matsushita Yosuke, Katagiri Toyomasa, Okamura Haruki, Miyoshi Yasuo. 早期乳癌患者における血清CCL5高値と良好な無病生存率との顕著な関連性(Significant association between high serum CCL5 levels and better disease-free survival of patients with early breast cancer). Cancer Science. 2020. 111. 1. 209-218
Fujimoto Yukie, Watanabe Takahiro, Hida Akira I., Higuchi Tomoko, Miyagawa Yoshimasa, Ozawa Hiromi, Bun Ayako, Fukui Reiko, Sata Atsushi, Imamura Michiko, et al. 腫瘍浸潤リンパ球の予後的意義は、エストロゲン受容体陽性/HER2陰性の手術乳癌におけるKi67発現レベルに依存して異なる可能性がある(Prognostic significance of tumor-infiltrating lymphocytes may differ depending on Ki67 expression levels in estrogen receptor-positive/HER2-negative operated breast cancers). Breast Cancer. 2019. 26. 6. 738-747
